Corresponding doses of mometasone furoate (MF) in once-daily inhaled fixed-dose combination (FDC) of indacaterol/mometasone furoate (IND/MF) and indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF): results from randomized clinical studies

IND/GLY/MF and IND/MF are both once-daily (o.d.) FDCs, recently approved for maintenance treatment of asthma. They have been developed with different MF doses with the goal to tailor therapy to a patient ’s needs.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research